Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model
Authors:
- Michael WolztMWMichael Wolzt
- Kurt KrejcyKKKurt Krejcy
- Ursula GraselliUGUrsula Graselli
- Oliver FindlOFOliver Findl
- Hans-Georg EichlerHEHans-Georg Eichler
- Ernst A. SingerESErnst A. Singer
- 1 August 1996
- journal article
- clinical trial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 60 (2) , 199-205
Abstract
Sumatriptan is a selective 5-hydroxytryptamine1d (5-HT1d)-receptor agonist, highly effective in the short-term treatment of migraine headaches. However, the mechanism underlying the action of sumatriptan is not yet completely understood. To further characterize the vascular effects of sumatriptan, we studied the effects on cerebral and ocular circulation in the well-established nitroglycerin headache model. In a double-blind, placebo-controlled, randomized, two-way crossover study in 10 healthy male subjects, we administered either placebo plus nitroglycerin or sumatriptan plus nitroglycerin. Blood flow velocity in the middle cerebral artery and the ophthalmic artery, as well as ocular fundus pulsations and systemic hemodynamic parameters, were measured after sumatriptan and placebo and during the following infusion of nitroglycerin. After infusion of nitroglycerin, blood flow velocity in the middle cerebral decreased by -13.3% versus baseline after placebo pretreatment, but by only -2.2% after sumatriptan (treatment effect, +10.8%; p < 0.05). In contrast, sumatriptan had no effect in the ophthalmic artery. Ocular fundus pulsations, which estimate local pulsatile ocular blood flow, were slightly reduced after sumatriptan. Moreover, sumatriptan partially prevented the increase in fundus pulsations during nitroglycerin infusion (treatment effect, -5.4%; p < 0.05). Sumatriptan prevents the effect of nitroglycerin-induced vasodilation in the middle cerebral artery but not in the ophthalmic artery, which strongly supports the concept that sumatriptan directly vasoconstricts distended basal cerebral arteries. Measurement of ocular fundus pulsations indicates that sumatriptan also has a small vasoconstrictor action on resistance vessels.Keywords
This publication has 25 references indexed in Scilit:
- A Randomized, Placebo-controlled, Double-blind Crossover Study of the Effect of Pentoxifylline on Ocular Fundus PulsationsAmerican Journal of Ophthalmology, 1996
- Comparison of non‐invasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: sex differences in cardiovascular responsiveness.British Journal of Clinical Pharmacology, 1995
- Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.Circulation, 1993
- Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacksNeurology, 1992
- Sumatriptan and cerebral perfusion in healthy volunteers.British Journal of Clinical Pharmacology, 1992
- Color Doppler Imaging of the Eye and OrbitArchives of Ophthalmology (1950), 1991
- 5‐Hydroxtryptamine 1D Receptor Agonism Predicts Antimigraine EfficacyHeadache: The Journal of Head and Face Pain, 1991
- Role of 5‐HT1‐like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptanBritish Journal of Pharmacology, 1991
- Neuropeptide Release from Sensory Fibres of Guinea Pig Cerebral Venous Sinuses and Dorsal Spinal Cord: Relevance for Headache StudyCephalalgia, 1989
- Blood flow in the human eyeActa Ophthalmologica, 1989